These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25010110)

  • 21. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Leister F; Krivogorsky B; Yolken RH
    Bipolar Disord; 2006 Apr; 8(2):124-32. PubMed ID: 16542182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels.
    Hamdani N; Daban-Huard C; Lajnef M; Gadel R; Le Corvoisier P; Delavest M; Carde S; Lépine JP; Jamain S; Houenou J; Galeh B; Richard JR; Aoki M; Charron D; Krishnamoorthy R; Yolken R; Dickerson F; Tamouza R; Leboyer M
    J Affect Disord; 2015 Jul; 179():161-6. PubMed ID: 25863913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) to investigate group and gender differences in schizophrenia and bipolar disorder.
    Gogos A; Joshua N; Rossell SL
    Aust N Z J Psychiatry; 2010 Mar; 44(3):220-9. PubMed ID: 20050718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Toxoplasma gondii antibodies in patients with schizophrenia--preliminary findings in a Turkish sample.
    Cetinkaya Z; Yazar S; Gecici O; Namli MN
    Schizophr Bull; 2007 May; 33(3):789-91. PubMed ID: 17404388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological survey of Toxoplasma gondii in schizophrenia patients referred to Psychiatric Hospital, Sari City, Iran.
    Ahmad D; Mehdi S; Sayed HH; Sayed AK; Shirzad G
    Trop Biomed; 2010 Dec; 27(3):476-82. PubMed ID: 21399589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive functions in bipolar affective disorder and schizophrenia: comparison.
    Pradhan BK; Chakrabarti S; Nehra R; Mankotia A
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):515-25. PubMed ID: 18950370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia.
    Yolken RH; Bachmann S; Ruslanova I; Lillehoj E; Ford G; Torrey EF; Schroeder J
    Clin Infect Dis; 2001 Mar; 32(5):842-4. PubMed ID: 11229859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of Toxoplasma gondii among patients with schizophrenia and bipolar disorder in Upper Egypt: a comparative study with a control group.
    Hussein EAM; Khalifa H; Ramadan GK; Hassaan SH; Shaaban I; Farrag HMM
    Ann Parasitol; 2020; 66(2):183-192. PubMed ID: 32592457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: potential relationship with latent Toxoplasma Gondii infection.
    Hamdani N; Bengoufa D; Godin O; Doukhan R; Le Guen E; Daban-Huard C; Bennabi M; Delavest M; Lépine JP; Boukouaci W; Laouamri H; Houenou J; Jamain S; Richard JR; Lecorvosier P; Yolken R; Rajagopal K; Leboyer M; Tamouza R
    BMC Psychiatry; 2018 Jul; 18(1):239. PubMed ID: 30053866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia.
    Wang HL; Wang GH; Li QY; Shu C; Jiang MS; Guo Y
    Acta Psychiatr Scand; 2006 Jul; 114(1):40-8. PubMed ID: 16774660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive functioning in euthymic bipolar I and bipolar II patients.
    Dittmann S; Hennig-Fast K; Gerber S; Seemüller F; Riedel M; Emanuel Severus W; Langosch J; Engel RR; Möller HJ; Grunze HC
    Bipolar Disord; 2008 Dec; 10(8):877-87. PubMed ID: 19594503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.
    Green MF
    J Clin Psychiatry; 2006; 67 Suppl 9():3-8; discussion 36-42. PubMed ID: 16965182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive functioning of bipolar I patients and relatives from families with or without schizophrenia or schizoaffective disorder.
    Antila M; Partonen T; Kieseppä T; Suvisaari J; Eerola M; Lönnqvist J; Tuulio-Henriksson A
    J Affect Disord; 2009 Jul; 116(1-2):70-9. PubMed ID: 19117610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [How to differentiate schizophrenia from bipolar disorder using cognitive assessment?].
    Demily C; Jacquet P; Marie-Cardine M
    Encephale; 2009 Apr; 35(2):139-45. PubMed ID: 19393382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Ruslanova I; Yolken RH
    Arch Gen Psychiatry; 2003 May; 60(5):466-72. PubMed ID: 12742867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Routine clinical assessment of cognitive functioning in schizophrenia, major depressive disorder, and bipolar disorder.
    Belgaied W; Samp J; Vimont A; Rémuzat C; Aballéa S; El Hammi E; Kooli A; Toumi M; Akhras K
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):133-41. PubMed ID: 24314852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosocial function in schizophrenia and bipolar disorder: Relationship to neurocognition and clinical symptoms.
    Simonsen C; Sundet K; Vaskinn A; Ueland T; Romm KL; Hellvin T; Melle I; Friis S; Andreassen OA
    J Int Neuropsychol Soc; 2010 Sep; 16(5):771-83. PubMed ID: 20509984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia.
    Dickerson F; Stallings C; Origoni A; Vaughan C; Khushalani S; Yolken R
    Schizophr Res; 2012 Jan; 134(1):83-8. PubMed ID: 22048011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of circulating toxoplasma gondii DNA in seropositive patients with bipolar or schizophrenia spectrum disorders.
    Galli L; Del Grande C; Rindi L; Mangia C; Mangano V; Schiavi E; Masci I; Pinto B; Kramer L; Dell'Osso L; Bruschi F
    Psychiatry Res; 2019 Mar; 273():706-711. PubMed ID: 31207856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.